Literature DB >> 25016641

A polymer-protein core-shell nanomedicine for inhibiting cancer migration followed by photo-triggered killing.

Ranjith Ramachandran, Giridharan Loghanathan Malarvizhi, Parwathy Chandran, Neha Gupta, Deepthy Menon, Dilip Panikar, Shantikumar Nair, Manzoor Koyakutty.   

Abstract

Migratory capacity of cancer plays a critical role in the process of metastasis. Aberrant focal adhesions activated by the phosphorylation of Src kinase enables cancer cells to anchor on its micro-environment and migrate towards biochemically favorable niche, causing metastasis. Effective blocking of the migratory capacity of cancer cells by inhibiting protein kinases and subsequent application of cytotoxic stress may provide better therapeutic outcome. Here, we report a novel core-shell nanomedicine that inhibits cancer migration by nano-shell and impart reactive oxygen stress by laser assisted photosensitization of nano-core. For this, we have optimized a polymer-protein nanoconstruct where a photosensitizer (5,10,15, 20-tetrakis(meso-hydroxyphenyl)porphyrin (mTHPP) is loaded into poly(lactic-co-glycolic acid) (PLGA) nano-core and Src kinase inhibitor (dasatinib) is loaded into albumin nano-shell. The polymer-core was prepared by electrospray technique and albumin-shell was formed by alcohol coacervation. Transmission electron microscopy studies revealed the formation of - 80 nm sized nano-core decorated with - 10 nm size nano-shell. Successful incorporation of monomeric mTHPP in nano-core resulted improved photo-physical properties and singlet oxygen release under physiological conditions compared to free-mTHPP. Core-shell nanomedicine also showed dose and time dependent cellular uptake in U87MG glioma cells. Dasatinib released from nano-shell caused down regulation of phospho-Src leading to significant impairment of cancer migration and subsequent laser assisted photosensitization of nano-core resulted in the release of reactive oxygen stress leading to apoptosis of spatially confined cancer cells. In vivo studies on Wistar rats indicated the absence of any significant toxicity caused by the intravenous administration of nanomedicine. These results clearly show the advantage of core-shell nanomedicine mediated combinatorial approach for inhibiting important cancer signalling pathways togother with imparting cytotoxic stress.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25016641     DOI: 10.1166/jbn.2014.1847

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  4 in total

1.  Effect of pterostilbene on glioma cells and related mechanisms.

Authors:  Liang Yu; Zhendong Zhong; Hongbin Sun; Linxia Yan; Baomin He; Supin Li; Shuai Ma; Lili Yang; Yulan Huang
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 2.  Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer.

Authors:  Yijing Liu; Pravin Bhattarai; Zhifei Dai; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2019-04-01       Impact factor: 54.564

3.  Theranostic 3-Dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma.

Authors:  Ranjith Ramachandran; Vijayabhaskar Reddy Junnuthula; G Siddaramana Gowd; Anusha Ashokan; John Thomas; Reshmi Peethambaran; Anoop Thomas; Ayalur Kodakara Kochugovindan Unni; Dilip Panikar; Shantikumar V Nair; Manzoor Koyakutty
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

Review 4.  Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy.

Authors:  Wenjing Xu; Chunping Ye; Xin Qing; Shengli Liu; Xinyi Lv; Wenjun Wang; Xiaochen Dong; Yewei Zhang
Journal:  Mater Today Bio       Date:  2022-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.